T27 Fear of endocrine/metabolic dis other (ICD-10:Z71.1)

Introduction

Fear endocrine/metabolic disorder is a condition characterized by excessive fear or anxiety related to endocrine or metabolic disorders. It is important to diagnose and treat this condition to improve the patient’s quality of life and overall well-being. This guide aims to provide a comprehensive approach to diagnosing and managing fear endocrine/metabolic disorder.

Codes

• ICPC-2 Code: T27 Fear of endocrine/metabolic dis other^[1]
• ICD-10 Code: Z71.1 Person with feared complaint in whom no diagnosis is made^[2]

Symptoms

• Excessive fear or anxiety related to endocrine or metabolic disorders^[3]
• Persistent worry or concern about the potential consequences of these disorders
• Avoidance of activities or situations related to endocrine or metabolic disorders
• Physical symptoms such as increased heart rate, sweating, trembling, or shortness of breath when exposed to triggers related to endocrine or metabolic disorders^[4]

Causes

• Previous traumatic experience related to endocrine or metabolic disorders
• Genetic predisposition to anxiety disorders^[5]
• Imbalance of hormones or metabolic processes in the body^[6]

Diagnostic Steps

Medical History

• Gather information about the patient’s previous experiences with endocrine or metabolic disorders
• Identify any risk factors or family history of anxiety disorders
• Assess the patient’s current symptoms and their impact on daily functioning^[7]

Physical Examination

• Perform a thorough physical examination to rule out any underlying medical conditions that may be contributing to the patient’s symptoms
• Look for signs of hormonal imbalances or metabolic abnormalities^[8]

Laboratory Tests

• Blood tests to assess hormone levels and metabolic markers
• Thyroid function tests to evaluate thyroid hormone levels
• Glucose tolerance test to assess for diabetes or impaired glucose metabolism^[9]

Diagnostic Imaging

• Imaging modalities such as ultrasound or MRI may be used to visualize endocrine organs or assess for any structural abnormalities
• CT scans may be used to evaluate the adrenal glands or other endocrine organs^[10]

Other Tests

• Genetic testing may be considered to identify any genetic predisposition to anxiety disorders or endocrine/metabolic disorders
• Psychological assessments or questionnaires may be used to further evaluate the patient’s anxiety symptoms and their impact on daily functioning

Follow-up and Patient Education

• Schedule regular follow-up appointments to monitor the patient’s progress and adjust treatment as needed
• Provide education to the patient about their condition, including the underlying endocrine or metabolic disorder and the role of anxiety in exacerbating symptoms
• Encourage the patient to seek support from mental health professionals or support groups to help manage their anxiety and fears

Possible Interventions

Traditional Interventions

Medications:

Top 5 drugs for fear endocrine/metabolic disorder:

1. Selective serotonin reuptake inhibitors (SSRIs) (e.g., Sertraline, Fluoxetine):
   • Cost: Generic versions can be $3-$50/month.
   • Contraindications: Hypersensitivity to SSRIs, concomitant use with monoamine oxidase inhibitors (MAOIs).
   • Side effects: Nausea, headache, insomnia.
   • Severe side effects: Serotonin syndrome, suicidal thoughts.
   • Drug interactions: MAOIs, other serotonergic drugs.
   • Warning: May take several weeks to achieve full therapeutic effect.
2. Benzodiazepines (e.g., Alprazolam, Diazepam):
   • Cost: Generic versions can be $3-$50/month.
   • Contraindications: Acute narrow-angle glaucoma, severe respiratory insufficiency.
   • Side effects: Sedation, dizziness, confusion.
   • Severe side effects: Respiratory depression, dependence.
   • Drug interactions: Alcohol, other CNS depressants.
   • Warning: Risk of dependence and withdrawal symptoms with long-term use.
3. Beta-blockers (e.g., Propranolol, Atenolol):
   • Cost: Generic versions are typically <$30/month.
   • Contraindications: Severe bradycardia, heart block.
   • Side effects: Fatigue, dizziness, bradycardia.
   • Severe side effects: Bronchospasm, heart failure.
   • Drug interactions: Calcium channel blockers, insulin.
   • Warning: Should not be abruptly stopped.
4. Antidepressants (e.g., Venlafaxine, Duloxetine):
   • Cost: Generic versions can be $3-$50/month.
   • Contraindications: Hypersensitivity to antidepressants, concomitant use with MAOIs.
   • Side effects: Nausea, headache, insomnia.
   • Severe side effects: Serotonin syndrome, suicidal thoughts.
   • Drug interactions: MAOIs, other serotonergic drugs.
   • Warning: May take several weeks to achieve full therapeutic effect.
5. Antipsychotics (e.g., Quetiapine, Risperidone):
   • Cost: Generic versions can be $3-$50/month.
   • Contraindications: Hypersensitivity to antipsychotics, dementia-related psychosis.
   • Side effects: Sedation, weight gain, extrapyramidal symptoms.
   • Severe side effects: Neuroleptic malignant syndrome, tardive dyskinesia.
   • Drug interactions: Other antipsychotics, CNS depressants.
   • Warning: Increased risk of mortality in elderly patients with dementia-related psychosis.

Alternative Drugs:

• Buspirone: An anxiolytic medication that does not cause sedation or dependence.
• Hydroxyzine: An antihistamine with anxiolytic properties.
• Pregabalin: An anticonvulsant medication used for anxiety disorders.
• Gabapentin: Another anticonvulsant medication used for anxiety disorders.
• Mirtazapine: An atypical antidepressant with anxiolytic properties.

Surgical Procedures:

• Surgical interventions are not typically indicated for fear endocrine/metabolic disorder. However, in cases where there is an underlying endocrine or metabolic disorder that requires surgical management, appropriate surgical procedures may be considered.

Alternative Interventions

• Cognitive-behavioral therapy (CBT): A form of psychotherapy that focuses on identifying and changing negative thought patterns and behaviors. Cost: $100-$200 per session.
• Mindfulness-based stress reduction (MBSR): A meditation-based program that helps individuals develop awareness and acceptance of their thoughts and emotions. Cost: $200-$400 for an 8-week program.
• Exercise therapy: Regular physical activity has been shown to reduce anxiety symptoms. Cost: Varies depending on the type of exercise and location (e.g., gym membership, fitness classes).
• Relaxation techniques: Techniques such as deep breathing, progressive muscle relaxation, and guided imagery can help reduce anxiety. Cost: Free or minimal cost for instructional materials or classes.
• Support groups: Joining a support group can provide a sense of community and understanding. Cost: Varies depending on the organization or group (some may be free, while others may require a membership fee).

Lifestyle Interventions

• Healthy diet: A balanced diet rich in fruits, vegetables, whole grains, and lean proteins can support overall well-being and may help reduce anxiety symptoms. Cost: Varies depending on individual food choices.
• Regular exercise: Engaging in regular physical activity can help reduce anxiety and improve overall mental health. Cost: Varies depending on the type of exercise and location.
• Stress management techniques: Practicing stress management techniques such as meditation, yoga, or journaling can help reduce anxiety. Cost: Free or minimal cost for instructional materials or classes.
• Adequate sleep: Getting enough quality sleep is important for overall mental health. Establishing a regular sleep routine and creating a comfortable sleep environment can help improve sleep quality. Cost: Varies depending on individual needs (e.g., bedding, sleep aids).
• Avoidance of triggers: Identifying and avoiding triggers that exacerbate anxiety symptoms related to endocrine or metabolic disorders can help manage fear and anxiety. Cost: Free.

It is important to note that the cost ranges provided are approximate and may vary depending on the location and availability of the interventions. It is recommended to consult with healthcare professionals or insurance providers for more accurate cost information.

Mirari Cold Plasma Alternative Intervention

Understanding Mirari Cold Plasma

• Safe and Non-Invasive Treatment: Mirari Cold Plasma is a safe and non-invasive treatment option for various skin conditions. It does not require incisions, minimizing the risk of scarring, bleeding, or tissue damage.
• Efficient Extraction of Foreign Bodies: Mirari Cold Plasma facilitates the removal of foreign bodies from the skin by degrading and dissociating organic matter, allowing easier access and extraction.
• Pain Reduction and Comfort: Mirari Cold Plasma has a local analgesic effect, providing pain relief during the treatment, making it more comfortable for the patient.
• Reduced Risk of Infection: Mirari Cold Plasma has antimicrobial properties, effectively killing bacteria and reducing the risk of infection.
• Accelerated Healing and Minimal Scarring: Mirari Cold Plasma stimulates wound healing and tissue regeneration, reducing healing time and minimizing the formation of scars.

Mirari Cold Plasma Prescription

Video instructions for using Mirari Cold Plasma Device – T27 Fear of endocrine/metabolic dis other (ICD-10:Z71.1)

Localized (0) Sacrum (1) Prostate & Uterus (2) Kidney, Liver & Spleen (3) Heart, Bile & Pancreas (4) Lungs (5) Throat, Lymphatic & Thyroid (6) Neuro system & ENT (7)

Use the Mirari Cold Plasma device to treat Fear endocrine/metabolic disorder effectively.

WARNING: MIRARI COLD PLASMA IS DESIGNED FOR THE HUMAN BODY WITHOUT ANY ARTIFICIAL OR THIRD PARTY PRODUCTS. USE OF OTHER PRODUCTS IN COMBINATION WITH MIRARI COLD PLASMA MAY CAUSE UNPREDICTABLE EFFECTS, HARM OR INJURY. PLEASE CONSULT A MEDICAL PROFESSIONAL BEFORE COMBINING ANY OTHER PRODUCTS WITH USE OF MIRARI.

Step 1: Cleanse the Skin

• Start by cleaning the affected area of the skin with a gentle cleanser or mild soap and water. Gently pat the area dry with a clean towel.

Step 2: Prepare the Mirari Cold Plasma device

• Ensure that the Mirari Cold Plasma device is fully charged or has fresh batteries as per the manufacturer’s instructions. Make sure the device is clean and in good working condition.
• Switch on the Mirari device using the power button or by following the specific instructions provided with the device.
• Some Mirari devices may have adjustable settings for intensity or treatment duration. Follow the manufacturer’s instructions to select the appropriate settings based on your needs and the recommended guidelines.

Step 3: Apply the Device

• Place the Mirari device in direct contact with the affected area of the skin. Gently glide or hold the device over the skin surface, ensuring even coverage of the area experiencing.
• Slowly move the Mirari device in a circular motion or follow a specific pattern as indicated in the user manual. This helps ensure thorough treatment coverage.

Step 4: Monitor and Assess:

• Keep track of your progress and evaluate the effectiveness of the Mirari device in managing your Fear endocrine/metabolic disorder. If you have any concerns or notice any adverse reactions, consult with your health care professional.

Note

This guide is for informational purposes only and should not replace the advice of a medical professional. Always consult with your healthcare provider or a qualified medical professional for personal advice, diagnosis, or treatment. Do not solely rely on the information presented here for decisions about your health. Use of this information is at your own risk. The authors of this guide, nor any associated entities or platforms, are not responsible for any potential adverse effects or outcomes based on the content.

Mirari Cold Plasma System Disclaimer

• Purpose: The Mirari Cold Plasma System is a Class 2 medical device designed for use by trained healthcare professionals. It is registered for use in Thailand and Vietnam. It is not intended for use outside of these locations.
• Informational Use: The content and information provided with the device are for educational and informational purposes only. They are not a substitute for professional medical advice or care.
• Variable Outcomes: While the device is approved for specific uses, individual outcomes can differ. We do not assert or guarantee specific medical outcomes.
• Consultation: Prior to utilizing the device or making decisions based on its content, it is essential to consult with a Certified Mirari Tele-Therapist and your medical healthcare provider regarding specific protocols.
• Liability: By using this device, users are acknowledging and accepting all potential risks. Neither the manufacturer nor the distributor will be held accountable for any adverse reactions, injuries, or damages stemming from its use.
• Geographical Availability: This device has received approval for designated purposes by the Thai and Vietnam FDA. As of now, outside of Thailand and Vietnam, the Mirari Cold Plasma System is not available for purchase or use.

References

1. ICPC-2 – English. ICPC-2 – English. (n.d.). Retrieved from https://www.gesy.org.cy/el-gr/annualreport/icpc-2-english1-10.pdf
2. ICD-10 Version:2019. (n.d.). Retrieved from https://icd.who.int/browse10/2019/en
3. Hall, R. C. W. (n.d.). Anxiety and Endocrine Disease. Retrieved from http://www.drryanhall.com/anxiety.htm
4. Metabolic syndrome – Symptoms & causes. (2021, August 24). Mayo Clinic. Retrieved from https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/symptoms-causes/syc-20351916
5. Endocrine and metabolic disorders. – APA PsycNet. (n.d.). Retrieved from https://psycnet.apa.org/record/2010-23861-067
6. Irons, B. K. (n.d.). Endocrine and Metabolic Disorders. Retrieved from https://www.accp.com/docs/meetings/UT15/handouts/PPC15_Endocrine_Disorders_workbook.pdf
7. Metabolic and Endocrine Disorders – Physiopedia. (n.d.). Retrieved from https://www.physio-pedia.com/Metabolic_and_Endocrine_Disorders
8. Patient Education: Endocrine and Metabolic Disorders. (n.d.). Retrieved from https://endocrinology.wustl.edu/patient-care/patient-education/endocrine-and-metabolic-disorders/
9. Yu, J. (2015). Endocrine disorders and the neurologic manifestations. Annals of Pediatric Endocrinology & Metabolism, 20(1), 8-13. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316409/
10. New Insights and Potential Therapeutic Interventions in Metabolic Diseases. (2023). International Journal of Molecular Sciences, 24(12), 10342. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342188/